Page last updated: 2024-09-04

carbapenems and Infant, Premature, Diseases

carbapenems has been researched along with Infant, Premature, Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chikviladze, D; Gachechiladze, K; Kobeshavidze, N; Mikeladze, M1
Benjamin, DK; Cotten, CM; Goldberg, RN; McDonald, S; Poole, K; Stoll, B1

Other Studies

2 other study(ies) available for carbapenems and Infant, Premature, Diseases

ArticleYear
[ANALYSIS OF THE USE OF ANTIBIOTIC THERAPY IN PREMATURE INFANTS, TAKING INTO ACCOUNT THE CHARACTERISTICS OF THE NEONATAL PERIOD].
    Georgian medical news, 2020, Issue:298

    Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Microbial Sensitivity Tests; Respiratory System

2020
The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants.
    Pediatrics, 2006, Volume: 118, Issue:2

    Topics: Blood; Candidiasis; Carbapenems; Catheterization, Central Venous; Central Nervous System Fungal Infections; Cephalosporins; Cerebrospinal Fluid; Comorbidity; Cross Infection; Enterocolitis, Necrotizing; Fungemia; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Prospective Studies; Registries; Risk Factors; Superinfection

2006